Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
Monoclonal antibodies (MAbs) were obtained by immunizing mice with synthetic peptides corresponding to the third variable (V3) or the third conserved (C3) domain of the external envelope protein (gp120) of human immunodeficiency virus type 2 (HIV-2ROD). One MAb, designated B2C, which was raised agai...
保存先:
| 出版年: | J Virol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7538171/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.6.3333-3340.1995 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
